Zeitschrift für Neurologie und Neurowissenschaften

  • ISSN: 2171-6625
  • H-Index der Zeitschrift: 17
  • Zitierbewertung der Zeitschrift: 4.43
  • Journal-Impact-Faktor: 3.38
Indiziert in
  • Öffnen Sie das J-Tor
  • Genamics JournalSeek
  • Der Global Impact Factor (GIF)
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • Verzeichnis der Indexierung von Forschungszeitschriften (DRJI)
  • OCLC – WorldCat
  • Proquest-Vorladungen
  • Wissenschaftlicher Journal Impact Factor (SJIF)
  • Euro-Pub
  • Google Scholar
  • Geheime Suchmaschinenlabore
Teile diese Seite

Abstrakt

Evaluation of Wilson Disease With 18F-FDG PET/CT

Nudelman-Speckman A, Díaz-Meneses I, Valenzuela M and Kerik-Rottenberg N

Wilson disease is an autosomal-recessive disorder with copper accumulation and deposition in different organs. Disturbances in liver function and basal ganglia lead to hepatic and extrapyramidal motor symptoms. Age of onset ranges from 5 to 40 years of age. Wilson disease should be ruled out by measuring serum ceruloplasmin levels, and 24-hour urinary copper levels. We report a case of a 30 year-old female who had experienced progressive dystonia for a year. A decreased uptake of glucose metabolism using 18F-Fluoro-desoxyglucose-Positron-Emission- Tomography/Computed-Tomography (18F-FDG PET/CT) in the striatal area has been reported in the literature. With low levels of ceruloplasmin, elevation of aminotransferase activity and 24-hour urinary copper levels, associated with PET results using 18F FDG led to the diagnosis of Wilson disease. This study shows the feasibility of using in vivo imaging FDG PET/CT for identification of Wilson disease when there is a high clinical suspicion.